“…Although the existing diagnostic criteria for CBD are not formally validated and definitive diagnosis is made only after neuropathological confirmation, Watts et al suggested akinesia, rigidity, postural or gait disturbance, postural and action tremor, alien limb phenomenon, dystonia, myoclonus as the major criteria for the disease diagnosis and choreoathetosis, dementia, blepharospasm, and cerebellar signs (like supranuclear gaze abnormalities) as the minor ones [4,5]. According to Riley et al, the clinical manifestations can be separated into those that appear as a result of basal ganglia impairment (eg akinesia, rigidity, dystonia, athetosis, postural instability), to those that have a cerebral cortex origin (eg alien limb phenomenon caused by cortical sensory loss, cognitive decline) and other features such as a postural-action tremor that often evolves to myoclonus, hyperreflexia, impaired ocular and eyelid motility, dysarthria and dysphagia [6]. The L-dopa response is poor.…”